Keros Therapeutics Inc

The current institutional shareholding score of Keros Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 114.30%, representing a quarter-over-quarter increase of 16.94%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.30% of shares outstanding, with 0.38% increase in holdings.